Cargando…
Development in PaCO(2) over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled trial
INTRODUCTION: Persistent hypercapnic failure in chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. Long-term home non-invasive ventilation is recommended for patients with PaCO(2) >7.0 kPa. Domiciliary high-flow nasal cannula (HFNC) reduces PaCO(2) in short-term studi...
Autores principales: | Storgaard, Line Hust, Hockey, Hans-Ulrich, Weinreich, Ulla Møller |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677330/ https://www.ncbi.nlm.nih.gov/pubmed/33208303 http://dx.doi.org/10.1136/bmjresp-2020-000712 |
Ejemplares similares
-
High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial
por: Alnajada, Asem, et al.
Publicado: (2021) -
High-pressure NIV for acute hypercapnic respiratory failure in COPD: improved survival in a retrospective cohort study
por: Hedsund, Caroline, et al.
Publicado: (2022) -
High-intensity non-invasive ventilation during exercise-training versus without in people with very severe COPD and chronic hypercapnic respiratory failure: a randomised controlled trial
por: Schneeberger, Tessa, et al.
Publicado: (2023) -
Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure
por: Storgaard, Line Hust, et al.
Publicado: (2018) -
Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure
por: Sørensen, Sabrina Storgaard, et al.
Publicado: (2021)